These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2067766)

  • 1. Oxytocin augmentation of labor and perinatal outcome in nulliparas.
    Akoury HA; MacDonald FJ; Brodie G; Caddick R; Chaudhry NM; Frize M
    Obstet Gynecol; 1991 Aug; 78(2):227-30. PubMed ID: 2067766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of 15- and 40-minute dosing protocols for labor augmentation and induction.
    Lazor LZ; Philipson EH; Ingardia CJ; Kobetitsch ES; Curry SL
    Obstet Gynecol; 1993 Dec; 82(6):1009-12. PubMed ID: 8233251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Currently used oxytocin regimen outcome measures at term & postterm. I: Outcome indicators in relation to parity & indication for induction.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):235-42. PubMed ID: 18330323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does prostaglandin confer significant advantage over oxytocin infusion for nulliparas with pre-labor rupture of membranes at term?
    Chua S; Arulkumaran S; Kurup A; Anandakumar C; Tay D; Ratnam SS
    Obstet Gynecol; 1991 May; 77(5):664-7. PubMed ID: 2014076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin augmentation of labor: a comparison of 15- and 30-minute dose increment intervals.
    Foster TC; Jacobson JD; Valenzuela GJ
    Obstet Gynecol; 1988 Feb; 71(2):147-9. PubMed ID: 3336546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective comparison of hourly and quarter-hourly oxytocin dose increase intervals for the induction of labor at term.
    Blakemore KJ; Qin NG; Petrie RH; Paine LL
    Obstet Gynecol; 1990 May; 75(5):757-61. PubMed ID: 2325960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised controlled trial of early versus delayed oxytocin augmentation to treat primary dysfunctional labour in nulliparous women.
    Hinshaw K; Simpson S; Cummings S; Hildreth A; Thornton J
    BJOG; 2008 Sep; 115(10):1289-95; discussion 1295-6. PubMed ID: 18715415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile administration of oxytocin for augmentation of labor.
    Cummiskey KC; Gall SA; Dawood MY
    Obstet Gynecol; 1989 Dec; 74(6):869-72. PubMed ID: 2685676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The continuing effectiveness of active management of first labor, despite a doubling in overall nulliparous cesarean delivery.
    Foley ME; Alarab M; Daly L; Keane D; Rath A; O'herlihy C
    Am J Obstet Gynecol; 2004 Sep; 191(3):891-5. PubMed ID: 15467560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent oxytocin with dinoprostone pessary versus dinoprostone pessary in labour induction of nulliparas with an unfavourable cervix: a randomised placebo-controlled trial.
    Tan PC; Valiapan SD; Tay PY; Omar SZ
    BJOG; 2007 Jul; 114(7):824-32. PubMed ID: 17506788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of currently used oxytocin regimen and prospects.
    Berhan Y; Dwivedi AD
    Ethiop Med J; 2007 Jul; 45(3):225-34. PubMed ID: 18330322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primiparas with or without oxytocin augmentation: a prospective descriptive study.
    Svärdby K; Nordström L; Sellström E
    J Clin Nurs; 2007 Jan; 16(1):179-84. PubMed ID: 17181680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile administration enhances the effect and reduces the dose of oxytocin required for induction of labor.
    Randolph GW; Fuchs AR
    Am J Perinatol; 1989 Apr; 6(2):159-66. PubMed ID: 2712912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in the rate of cesarean birth with active management of labor and intermediate-dose oxytocin.
    Gerhardstein LP; Allswede MT; Sloan CT; Lorenz RP
    J Reprod Med; 1995 Jan; 40(1):4-8. PubMed ID: 7722974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of orally administered misoprostol to intravenous oxytocin for labor induction in women with favorable cervical examinations.
    Wing DA; Fassett MJ; Guberman C; Tran S; Parrish A; Guinn D
    Am J Obstet Gynecol; 2004 Jun; 190(6):1689-94; discussion 1694-6. PubMed ID: 15284771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental increases in oxytocin infusion regimens for induction of labor at term in primigravidas: a randomized controlled trial.
    Orhue AA
    Obstet Gynecol; 1994 Feb; 83(2):229-33. PubMed ID: 8290185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour--a randomised controlled trial.
    Dencker A; Berg M; Bergqvist L; Ladfors L; Thorsén LS; Lilja H
    BJOG; 2009 Mar; 116(4):530-6. PubMed ID: 19250364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amniotic fluid bacteria on the course of labor in nulliparous women at term.
    Silver RK; Gibbs RS; Castillo M
    Obstet Gynecol; 1986 Nov; 68(5):587-92. PubMed ID: 3763067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose oxytocin: 20- versus 40-minute dosage interval.
    Satin AJ; Leveno KJ; Sherman ML; McIntire D
    Obstet Gynecol; 1994 Feb; 83(2):234-8. PubMed ID: 8290186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin.
    Hayes EJ; Weinstein L
    Am J Obstet Gynecol; 2008 Jun; 198(6):622.e1-7. PubMed ID: 18355786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.